Atsushi Sanbe Selected Research

alpha-Crystallin B Chain

1/2007	Interruption of CryAB-amyloid oligomer formation by HSP22.
11/2005	Mitochondrial dysfunction and apoptosis underlie the pathogenic process in alpha-B-crystallin desmin-related cardiomyopathy.
7/2004	Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atsushi Sanbe Research Topics

Disease

12	Cardiomyopathies (Cardiomyopathy) 09/2018 - 07/2004
9	Heart Failure 01/2020 - 04/2002
7	Neuroblastoma 01/2011 - 09/2006
6	Hypertrophy 09/2018 - 04/2002
4	Fibrosis (Cirrhosis) 09/2018 - 04/2002
4	Insulin Resistance 06/2009 - 06/2007
3	Cardiac Arrhythmias (Arrythmia) 01/2020 - 01/2014
3	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 09/2018 - 07/2004
3	Mitochondrial Diseases (Mitochondrial Disease) 05/2014 - 11/2005
2	Cataract (Cataracts) 01/2019 - 05/2015
2	Cardiomegaly (Heart Hypertrophy) 09/2018 - 03/2007
2	Proteostasis Deficiencies 01/2015 - 09/2011
2	Myocardial Infarction 05/2014 - 01/2013
2	Heart Diseases (Heart Disease) 01/2013 - 09/2005
2	Ischemia 01/2013 - 09/2011
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 09/2011 - 11/2003
2	Mood Disorders (Mood Disorder) 12/2010 - 12/2008
2	Hyperglycemia 11/2009 - 06/2009
2	Bipolar Disorder (Manic Depressive Psychosis) 11/2009 - 07/2008
2	Familial Hypertrophic Cardiomyopathy (Cardiomyopathy, Familial Hypertrophic) 05/2005 - 07/2002
1	Cognitive Dysfunction 10/2021
1	Body Weight (Weight, Body) 09/2018
1	Postpartum Depression (Post-Natal Depression) 11/2015
1	Muscular Diseases (Myopathy) 08/2014
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 08/2014
1	Ventricular Premature Complexes (Premature Ventricular Contraction) 01/2014
1	Ventricular Tachycardia 01/2014
1	Hypertension (High Blood Pressure) 01/2013
1	Inflammation (Inflammations) 01/2013
1	Myocardial Ischemia (Ischemic Heart Diseases) 09/2011
1	Microcephaly 01/2011
1	Intellectual Disability (Idiocy) 01/2011
1	Microphthalmos 01/2011
1	Prognathism 01/2011
1	Drug-Related Side Effects and Adverse Reactions 01/2011
1	Ectrodactyly 01/2011
1	Type 2B Charcot-Marie-Tooth disease 11/2010
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 11/2010
1	Glucose Intolerance 06/2009
1	Hypoglycemia (Reactive Hypoglycemia) 06/2009
1	Neoplasms (Cancer) 07/2008
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 07/2008
1	Epilepsy (Aura) 07/2008
1	Huntington Disease (Huntington's Disease) 05/2008
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2008

Drug/Important Bio-Agent (IBA)

10	DesminIBA 08/2014 - 07/2004
8	Proteins (Proteins, Gene)FDA Link 08/2014 - 04/2002
7	Small Heat-Shock ProteinsIBA 08/2014 - 07/2004
4	Pharmaceutical PreparationsIBA 01/2011 - 07/2008
4	Valproic Acid (Depakote)FDA LinkGeneric 11/2010 - 01/2007
4	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 11/2009 - 03/2007
4	Amyloid (Amyloid Fibrils)IBA 01/2009 - 07/2004
3	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 11/2015 - 12/2008
3	Mutant Proteins (Protein, Mutant)IBA 09/2011 - 11/2005
3	Vasopressins (Vasopressin)IBA 06/2009 - 03/2007
3	Glucose (Dextrose)FDA LinkGeneric 06/2009 - 05/2007
3	alpha-Crystallin B ChainIBA 01/2007 - 07/2004
2	Sodium-Glucose Transporter 1IBA 10/2021 - 09/2018
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 05/2014 - 03/2013
2	geranylgeranylacetone (teprenone)IBA 05/2014 - 01/2009
2	Angiotensin IIIBA 01/2014 - 11/2003
2	Sorting NexinsIBA 01/2011 - 11/2009
2	Insulin (Novolin)FDA Link 06/2009 - 10/2007
2	JNK Mitogen-Activated Protein KinasesIBA 07/2008 - 09/2006
2	PaxillinIBA 07/2008 - 05/2007
1	PhlorhizinIBA 10/2021
1	mizagliflozinIBA 10/2021
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 01/2020
1	CalciumIBA 01/2020
1	Collagen Type I (Type I Collagen)IBA 01/2019
1	salicylhydroxamic acid (SHAM)IBA 09/2018
1	Interleukin-18 (Interleukin 18)IBA 09/2018
1	Adrenergic Agents (Adrenergic Drugs)IBA 09/2018
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 09/2018
1	GlucocorticoidsIBA 05/2015
1	astaxanthine (astaxanthin)IBA 05/2015
1	KATP ChannelsIBA 01/2015
1	Crystallins (Crystallin)IBA 08/2014
1	Polyvinyl Chloride (PVC)IBA 01/2014
1	olmesartanIBA 01/2014
1	Nicorandil (SG 75)IBA 01/2014
1	Type 1 Angiotensin ReceptorIBA 01/2014
1	Muscle Proteins (Muscle Protein)IBA 01/2013
1	Proteasome Endopeptidase Complex (Proteasome)IBA 09/2011
1	mono(2-methacryloyloxy)ethyl phthalate (MMEP)IBA 01/2011
1	EnzymesIBA 01/2011
1	Monomeric GTP-Binding ProteinsIBA 11/2010
1	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 11/2009
1	LithiumIBA 11/2009
1	cytohesin-2IBA 07/2009
1	beta-CrystallinsIBA 01/2009
1	Fluoxetine (Prozac)FDA LinkGeneric 12/2008
1	Antidepressive Agents (Antidepressants)IBA 12/2008
1	Neurofibromin 2 (Merlin)IBA 07/2008
1	Peptides (Polypeptides)IBA 05/2008
1	polyglutamineIBA 05/2008

Therapy/Procedure

2	Ligation 05/2014 - 01/2013
1	Topical Administration 01/2019
1	Therapeutics 11/2015
1	Heart Transplantation (Grafting, Heart) 01/2013